ORIGINAL RESEARCH ARTICLE | Jan. 14, 2021
Prevention and Management of COVID-19 with Unani Medicine –A Review
M. U. Z. N. Farzana, Arshiya Sultana
Page no 1-10
The world is observing a very strange time fighting an invisible enemy; the novel Coronavirus disease 2019 (COVID-19). It is a declared global pandemic now. Initially it was observed in the Wuhan province of China, now fastly spreading around the world. The disease has spread globally with more than 8 million confirmed cases and 439,487 deaths as of June 17th, 2020. Human Coronavirus (HCoV) infection causes respiratory diseases with mild to severe outcomes. In the last 15 years, we have witnessed the emergence of two zoonotic, highly pathogenic HCoVs: Severe Acute Rspiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The most common symptoms of COVID-19 are fever, tiredness and dry cough. Some patients may have aches and pains, nasal congestion, runny nose, sore throat or diarrhoea and in case of serious illness develop difficulty in breathing. Research is underway to develop effective vaccines and medicines for the disease. But up to now no any effective management had not been declared. In such conditions, we present the measures described in Unani system of medicine for health protection during epidemics. Unani medicine is a traditional system of medicine developed during the middle ages, which employs natural drugs of herbal, animal and mineral origin for treatment. Traditional systems of medicine are being explored for providing preventive, supportive and rehabilitative care to patients in epidemic/pandemic but no direct evidence is available, some uncontrolled studies on traditional medicines suggest that they may have a direct efficacy on the virus. Unani Physicians emphasized in their classical Unani books under the chapter of influenza about pandemic (Nazla Wabai/ Nazla Haar) and epidemic diseases. The objective of this paper is to discuss in detail the Unani concept, management, treatment of epidemics in general and possible management of current Pandemics of COVID-19, its analysis in the light of ancient books in present scenario.
ORIGINAL RESEARCH ARTICLE | Jan. 30, 2021
Prevalence and Risk Factors of Hepatitis B infection in Pishin District, Pakistan
Sana Ullah, Fauzia Asmat, Mahrukh Naseem, AsmatUllah Kakar, ZafarUllah, Jahangheer Khan
Page no 11-14
The hepatitis B virus (HBV) infection is life-threatening in developing countries associated with high morbidity and mortality rate. The current study designed to figure out the prevalence, socio-demographic variable and associated risk factors of HBV in the local population of Pishin District, Pakistan. Under the well-sterilized condition, blood samples of 1457 individuals were collected weekly from Civil Hospital Pishin, during May 2019 to February 2020 for the screening of HBV infection. Patients were categorized into 2 age groups i. e. 1-30 years, 31-60 years. The HBsAg was detected by a commercially available ELISA kit. The overall prevalence of HBV was 38.36%. The incidence was higher in female (22.30%) than in male patients (16.06%). The socio-demographic finding showed that the prevalence was higher in patients with age group 31-60 years (20.93%), in married (30.19%), unvaccinated (19,56%) individuals and with poor economic status (20.93%). Furthermore, blood transfusion (23.03%), surgery (19.86%) and dental procedures (12.70%) were the major risk factors associated with the high prevalence of HBV infection in Pishin. In conclusion, the Pishin District was highly prevalent with HBV infection. This study may serve as a guideline for the local health care providers to optimize the health facilities. By conducting the public health awareness program, it is possible to reduce the prevalence of HBV by minimizing the associated risk factors.